Cell and Tissue Banking

, Volume 13, Issue 4, pp 587–596 | Cite as

The implementation of tissue banking experiences for setting up a cGMP cell manufacturing facility

  • Babak Arjmand
  • Seyed Hassan Emami-Razavi
  • Bagher Larijani
  • Abbas Norouzi-Javidan
  • Hamid Reza Aghayan


Cell manufacturing for clinical applications is a unique form of biologics manufacturing that relies on maintenance of stringent work practices designed to ensure product consistency and prevent contamination by microorganisms or by another patient’s cells. More extensive, prolonged laboratory processes involve greater risk of complications and possibly adverse events for the recipient, and so the need for control is correspondingly greater. To minimize the associate risks of cell manufacturing adhering to international quality standards is critical. Current good tissue practice (cGTP) and current good manufacturing practice (cGMP) are examples of general standards that draw a baseline for cell manufacturing facilities. In recent years, stem cell researches have found great public interest in Iran and different cell therapy projects have been started in country. In this review we described the role of our tissue banking experiences in establishing a new cGMP cell manufacturing facility. The authors concluded that, tissue banks and tissue banking experts can broaden their roles from preparing tissue grafts to manufacturing cell and tissue engineered products for translational researches and phase I clinical trials. Also they can collaborate with cell processing laboratories to develop SOPs, implement quality management system, and design cGMP facilities.


Cleanroom Clinical grade Tissue bank cGMP cGTP 



The authors would like to thank Dr. Hooshang Saberi, Dr. Masoud Soleimani, Dr. Seyed Mohammad-Javad Mortazavi, Dr. Saeed Sarkar, Mr. Saeed Zoughi, Mrs. Zahra Sarparast and Dr. Hassan Bahrami-nasab for their kindly collaborations.

Conflict of interest

The authors disclose that there is not any conflict of interests.


  1. Aghayan HR, Arjmand B, Emami-Razavi SH, Jafarian A, Shabanzadeh AR, Jalali F, Goodarzi P, Jebelifar S (2009) Organ donation workshop—a survey on nurses’ knowledge and attitudes toward organ and tissue donation in Iran. Int J Artif Organs 32(10):739–744PubMedGoogle Scholar
  2. Aghayan HR, Mahdavi-Mazdeh M, Goodarzi P, Arjmand B, Emami-Razavi SH (2010) Coding and traceability in Iran. Cell Tissue Bank 11(4):397–400PubMedCrossRefGoogle Scholar
  3. Aghayan HR, Arjmand B, Norouzi-Javidan A, Saberi H, Soleimani M, Tavakoli SA, Khodadadi A, Tirgar N, Mohammadi Jahani F (2011) Clinical grade cultivation of human schwann cell, by using human autologous serum instead of fetal bovine serum and without growth factors. Cell Tissue Bank. doi: 10.1007/s10561-011-9250-8
  4. Burger SR (2000) Design and operation of a current good manufacturing practices cell-engineering laboratory. Cytotherapy 2(2):111–122PubMedCrossRefGoogle Scholar
  5. Burger SR (2003) Current regulatory issue in cell and tissue therapy. Cytptherapy 5(4):289–298CrossRefGoogle Scholar
  6. Davis-Sproul J (1999) cGMP and cell processing. Cytotherapy 1(6):431–432PubMedCrossRefGoogle Scholar
  7. EudRalex (2010) Good manufacturing practice (GMP) Guidelines. Volume 4. http://ec.europa.eu/health/documents/eudralex/vol-4/index_en.htm
  8. European Medicines Agency (2008) Committee for Medicinal Products for Human Use GUIDELINE ON HUMAN CELL-BASED MEDICINAL PRODUCTS. Doc. Ref. EMEA/CHMP/410869/2006, London 21 May 2008Google Scholar
  9. Firouzi M, Moshayedi P, Saberi H, Mobasheri H, Abolhassani F, Jahanzad I, Raza M (2006) Transplantation of Schwann cells to subarachnoid space induces repair in contused rat spinal cord. Neurosci Lett 10 402(1–2):66–70CrossRefGoogle Scholar
  10. Freshney RI (2005) Culture of animal cells: a manual of basic technique, 5th edn. Wiley-Liss Inc., USA, pp 55Google Scholar
  11. Ghavamzadeh A, Iravani M, Jabehdar-Maralani P, Hajrasouliha A, Tavakoli S (2003) Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran. Haematologica 88(5):e67–e68Google Scholar
  12. Giordano R, Lazzari L, Rebulla P (2004) Clinical grade cell manipulation. Vox Sang 87:65–72PubMedCrossRefGoogle Scholar
  13. International Organization for Standardization (1999) Cleanrooms and associated controlled environments—Part 1: Classification of air cleanliness (ISO 14644-1:1999). ed 1, Switzerland, International Organization for Standardization publicationGoogle Scholar
  14. Marwaha N, Saluja K, Sharma RR (2007) Stem cell therapy: the need for current good manufacturing practices. Bull PGI 41:49–51Google Scholar
  15. Massarati S (2007) Stem cell therapy in Iran. Arch Iran Med 10(4):435–438Google Scholar
  16. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M (2007a) Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 10(4):459–466PubMedGoogle Scholar
  17. Mohyeddin Bonab M, Yazdanbakhsh S, Lotfi J, Alimoghaddom K, Talebian F (2007b) Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. Iran J Immunol 4(1):50–57PubMedGoogle Scholar
  18. Mohyeddin-Bonab M, Mohamad-Hassani MR, Alimoghaddam K, Sanatkar M, Ghasemi M (2007) Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch Iran Med 10(4):467–473PubMedGoogle Scholar
  19. Nassiri SM, Ahmadi SH, Khakil Z, Soleimani M, Jahanzad I, Rabbani S, Sahebjam M, Azmoudeh Ardalan F, Sheikh Fathollahi M (2007) Comparison between transepicardial cell transplantations: autologous undifferentiated versus differentiated marrow mesenchymal stem cells. J Tehran Univ Heart Center 2(1):25–30Google Scholar
  20. Niazi SK (2009) Handbook of pharmaceutical manufacturing formulations- sterile products, vol 6, 2nd edn. Informa Healthcare Inc., New York, pp 109–128Google Scholar
  21. Rowley SD (2000) Current good manufacturing practices: application to the processing of hematopoietic cell components. Cytotherapy 2(1):59–62PubMedCrossRefGoogle Scholar
  22. Saberi H, Moshayedi P, Aghayan HR, Arjmand B, Hosseini SK, Emami-Razavi SH, Rahimi-Movaghar V, Raza M, Firouzi M (2008) Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett 26 443(1):46–50CrossRefGoogle Scholar
  23. The United States Pharmacopeial Convention (2008a) United States Pharmacopeia 32 National Formulary 27: Cell and gene therapy products {1046}—Manufacturing of cell therapy productsGoogle Scholar
  24. The United States Pharmacopeial Convention (2008b) United States Pharmacopeia 32 National Formulary 27: Microbiological evaluation of clean rooms and other controlled environments {1116}Google Scholar
  25. Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O (2008) Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17:R48–R53PubMedCrossRefGoogle Scholar
  26. Yaghoubi M, Aghayan HR, Arjmand B, Emami-Razavi SH (2011) Cost-effectiveness of homograft heart valve replacement surgery: an introductory study. Cell Tissue Bank 12(2):153–158PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Babak Arjmand
    • 1
  • Seyed Hassan Emami-Razavi
    • 2
  • Bagher Larijani
    • 3
  • Abbas Norouzi-Javidan
    • 4
  • Hamid Reza Aghayan
    • 5
  1. 1.Endocrinology and Metabolism Research Center and Brain and Spinal Injury Repair Research CenterTehran University of Medical Sciences, Shariati HospitalTehranIran
  2. 2.Brain and Spinal Injury Repair Research CenterTehran University of Medical Sciences, BASIR Building, Imam-Khomeini HospitalTehranIran
  3. 3.Endocrinology and Metabolism Research CenterTehran University of Medical Sciences, Shariati HospitalTehranTran
  4. 4.Brain and Spinal Injury Repair Research CenterTehran University of Medical Sciences, BASIR Building, Imam-Khomeini HospitalTehranIran
  5. 5.Brain and Spinal Injury Repair Research Center and Endocrinology and Metabolism Research CenterTehran University of Medical Sciences, BASIR Building, Imam-Khomeini HospitalTehranIran

Personalised recommendations